Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for HealthLynked (HLYK) over the last 10 years, with Q3 2025 value amounting to $10911.0.

  • HealthLynked's Cash & Equivalents fell 2705.58% to $10911.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $10911.0, marking a year-over-year decrease of 2705.58%. This contributed to the annual value of $76241.0 for FY2024, which is 6916.09% down from last year.
  • Latest data reveals that HealthLynked reported Cash & Equivalents of $10911.0 as of Q3 2025, which was down 2705.58% from $20201.0 recorded in Q2 2025.
  • HealthLynked's 5-year Cash & Equivalents high stood at $5.4 million for Q3 2021, and its period low was $10911.0 during Q3 2025.
  • Over the past 5 years, HealthLynked's median Cash & Equivalents value was $172700.0 (recorded in 2024), while the average stood at $1.3 million.
  • In the last 5 years, HealthLynked's Cash & Equivalents surged by 192957.51% in 2021 and then tumbled by 9942.27% in 2024.
  • Quarter analysis of 5 years shows HealthLynked's Cash & Equivalents stood at $3.3 million in 2021, then plummeted by 98.12% to $61891.0 in 2022, then soared by 299.45% to $247222.0 in 2023, then plummeted by 69.16% to $76241.0 in 2024, then plummeted by 85.69% to $10911.0 in 2025.
  • Its Cash & Equivalents stands at $10911.0 for Q3 2025, versus $20201.0 for Q2 2025 and $22270.0 for Q1 2025.